• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Directed selection of amino acid changes in the influenza hemagglutinin and neuraminidase affecting protein antigenicity

tetano

Editor, Senior Moderator
Vaccine. 2018 Sep 14. pii: S0264-410X(18)31240-4. doi: 10.1016/j.vaccine.2018.09.005. [Epub ahead of print]
[h=1]Directed selection of amino acid changes in the influenza hemagglutinin and neuraminidase affecting protein antigenicity.[/h] DeDiego ML[SUP]1[/SUP], Chiem K[SUP]2[/SUP], Topham DJ[SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Influenza virus hemagglutinin (HA) and neuraminidase (NA) proteins elicit protective antibody responses and therefore, are used as targets for vaccination, especially the HA protein. However, these proteins are subject to antigenic drift, decreasing vaccine efficacy, and few to no studies have analyzed antigenic variability of these proteins by growing the viruses under immune pressure provided by human sera. In this work, we show that after growing different influenza virus strains under immune pressure, the selection of amino acid changes in the NA protein is much more limited than the selection in the HA protein, suggesting that the NA protein could remain more conserved under immune pressure. Interestingly, all the mutations in the HA and NA proteins affected protein antigenicity, and many of the selected amino acid changes were located at the same positions found in viruses circulating. These studies could help to inform HA and NA protein residues targeted by antibody responses after virus infection in humans and are very relevant to update the strains used for influenza virus vaccination each year and to improve the currently available vaccines.


[h=4]KEYWORDS:[/h] Antibodies; Antigenic drift; Hemagglutinin; Immune pressure; Influenza virus; Neuraminidase; Vaccines

PMID: 30224200 DOI: 10.1016/j.vaccine.2018.09.005
 
Back
Top Bottom